News
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
Gabapentin is routinely used to treat nerve pain and restless leg syndrome, but it might be riskier to our brain health than ...
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of dementia, a new study says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results